Dow Jones Futures Edge Higher as SP 500 and Nasdaq Reach New Highs AI Stocks Enter Buy Zones Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement in CNBC Interview Geopolitical Tensions Rise Russia Vows Retaliation Amid Ukraine Conflict Escalation US Consumer Prices Surge 38 in April Marking Fastest Annual Increase in Over Two Years OpenAI Takes Early Lead in AI IPO Race FirstMover Advantage Could Shape Market Direct Indexing Could Generate 19000 Annual Income on 700000 Portfolio SurgePays Inc SURG Q4 2025 Earnings Significant EPS Miss Amid Challenging Quarter PCG Q1 2026 Earnings EPS Beats Estimates by 187 as Utility Navigates Regulatory Landscape WGRX Q1 2026 Earnings Negative EPS and No Revenue Reported Stock Plunges 22 DGICA Q1 2026 Earnings EPS Falls Short of Estimates Community Healthcare Trust CHCT Q1 2026 Earnings Massive EPS Surprise of 449 Driven by Unusual Gains CNTN Q4 2023 Earnings EPS Surprises Positively Despite Revenue Absence Stock Declines 65 NMFC Slips 1 as Price Tests Key Support Levels OTGAW Warrants Hold Steady at 036 Amid Quiet Trading Support and Resistance Levels in Focus TotalEnergies TTE Slides 08 as Selling Pressure Intensifies Near Key Resistance Skyward Specialty Insurance Group SKWD Edges Higher Amid Steady Support Oportun Financial Corporation OPRT Inches Higher Testing Key Resistance Levels OpenAIs IPO Plans Could Mark Landmark Market Debut UTHR Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Southern Company Preferred Stock SOJE Edges Higher Testing Key Resistance XOMAO Preferred Shares Hold Steady Near 2532 as Yield Hunters Await Catalysts Equity Lifestyle Properties ELS Consolidates Near 62 After Modest 03 Decline Satellogic Warrants SATLW Plunge 11 Key Support Levels in Focus BlackRock Taxable Municipal Bond Trust BBN Edges Higher as IncomeSeeking Investors Return Tortoise Energy Infrastructure TYG Slips 11 as Energy Sector Faces Headwinds Marvell Technology MRVL Declines 46 as Bearish Pressure Intensifies Key Support Levels in Focus Nasus Pharma NSRX Gains 389 as Biotech Investors Eye Key Resistance